CD10, a cell surface zinc-dependent metalloprotease that could regulate the biological activities of various peptide substrates (19), has been proved to be correlated with tumor progression and aggressiveness in many cancers such as melanoma (20), colorectal cancer (21) and breast cancer (22). This evidence concerns the gene MME and breast carcinoma.